Figure 5. Prediction of chemotherapy and immunotherapy. (A, B) The relationship between the IRS score and the infiltration of immune cells. (C) Estimated IC50 of common chemical compounds between IRS_high and _low groups. (D) IPS scores between IRS_high and _low groups. (E, F) The correlation between IRS score and TME/TMB score. (G) Contingency table between immunotherapy responses (anti-PD-1 and anti-CTLA-4) and IRS groups based on SubMap analysis.